
Safety and Effectiveness of Tirzepatide (Mounjaro) for Weight Loss
Tirzepatide (Mounjaro), recently approved by the FDA, is a novel medication initially developed for type 2 diabetes. It also shows exceptional weight loss results by acting on both GIP and GLP-1 receptors, regulating appetite and blood sugar levels. In a landmark study published in the New England Journal of Medicine, patients lost an average of
Read more


